NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Will Anne Bramman’s Board Role Reframe Morningstar’s (MORN) Financial Oversight and Governance Narrative?

Morningstar, Inc. recently announced that Anne Bramman, a veteran finance leader with more than 30 years of experience across global companies, has been elected to its board of directors and appointed to the Audit and Compensation Committees. Her background as a former CFO and transformation leader in multiple industries positions her to influence Morningstar’s approach to financial oversight, modernization, and capital allocation. We will explore how Bramman’s extensive CFO and audit...
NYSE:AXP
NYSE:AXPConsumer Finance

Is It Too Late To Consider American Express (AXP) After Its Five Year 226.7% Surge

If you are wondering whether American Express is fairly priced after a strong run, this article will walk through what the current share price might be implying about future expectations. The stock last closed at US$375.61, with returns of 0.8% over the past week, 0.0% over the past month, 0.8% year to date, 29.4% over the past year and 226.7% over the past five years, which naturally raises questions about how much optimism is already in the price. Recent attention on American Express has...
NYSE:EXP
NYSE:EXPBasic Materials

A Look At Eagle Materials (EXP) Valuation As Shares Show Recent Momentum

Eagle Materials (EXP) has drawn fresh attention as investors weigh its recent share performance against fundamentals, including US$2,301.796m in revenue and US$446.799m in net income, alongside its current US$235.66 share price. See our latest analysis for Eagle Materials. The recent 1-day share price return of 6.66% and 7-day share price return of 11.45% point to building momentum, while the 0.75% 1-year total shareholder return and 115.09% 5-year total shareholder return show a much...
NasdaqGS:FTAI
NasdaqGS:FTAITrade Distributors

Is It Too Late To Consider FTAI Aviation (FTAI) After Its Recent Share Price Surge

If you are wondering whether FTAI Aviation's share price still reflects good value after its recent run, you are not alone. The stock most recently closed at US$245.73, with returns of 16.8% over the past week, 34.9% over the past month, 16.8% year to date, 42.6% over the past year and a very large gain over the past 3 years and 5 years. Recent coverage has focused on FTAI Aviation's position within the aviation sector and investor interest in its business model. This has helped keep the...
NYSE:BKH
NYSE:BKHIntegrated Utilities

A Look At Black Hills (BKH) Valuation After Completing The Ready Wyoming Transmission Project

Why Black Hills’ Ready Wyoming project matters for shareholders Black Hills (BKH) has just completed and energized its 260 mile, $350 million Ready Wyoming electric transmission expansion, linking its South Dakota and Wyoming systems and putting fresh attention on the stock. See our latest analysis for Black Hills. Despite the Ready Wyoming announcement and an upcoming 2025 earnings release in early February, Black Hills’ share price at $70.72 sits on a modest year to date gain of 1.54%,...
NYSE:MAS
NYSE:MASBuilding

Is Masco (MAS) Fairly Priced After Recent P/E Discount And DCF Outcome

If you are wondering whether Masco's current share price offers real value or just noise, you are not alone. The stock recently closed at US$69.32, with returns of 7.5% over the last 7 days, 9.3% over 30 days, 7.5% year to date and a 2.1% decline over 1 year, alongside 40.9% and 34.9% returns over 3 and 5 years. Recent news flow around Masco has focused on its position in the broader capital goods space and how investors are weighing its long term prospects against shorter term sentiment...
NYSE:BLX
NYSE:BLXDiversified Financial

Is Banco Latinoamericano De Comercio Exterior (BLX) Still Priced Attractively After Its Recent Run?

If you are wondering whether Banco Latinoamericano de Comercio Exterior S. A is still attractively priced after its recent run, this article will walk through what the current share price might imply about value. The stock closed at US$43.45, with returns of 26.7% over the past year, even though the last 7 days and 30 days saw returns of a 0.8% decline and a 3.5% decline respectively. Recent interest around BLX has largely centered on its role as a specialist trade finance bank for Latin...
NYSE:COMP
NYSE:COMPReal Estate

Assessing Compass (COMP) Valuation After Strong 1 Year Share Price and Revenue Performance

Compass (COMP) has drawn fresh attention after recent trading, with the stock showing sizable moves over the past month and past 3 months, even as the business continues to report a net loss alongside positive revenue growth. See our latest analysis for Compass. That momentum has not been limited to a few strong sessions, with a 90 day share price return of 82.39% and a 1 year total shareholder return of 140.00% pointing to building optimism around Compass’s prospects and risk profile at the...
NYSE:MSGE
NYSE:MSGEEntertainment

A Look At Madison Square Garden Entertainment (MSGE) Valuation After Record 2025 Christmas Spectacular Attendance

Madison Square Garden Entertainment (MSGE) is back in focus after announcing that its 2025 Christmas Spectacular, starring the Radio City Rockettes, drew more than 1.2 million attendees, the production's highest level in 25 years. See our latest analysis for Madison Square Garden Entertainment. Against this backdrop, Madison Square Garden Entertainment’s recent news arrives after a stretch of strong share price momentum. The stock has a 90 day share price return of 31.70% and a 1 year total...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Is It Too Late To Consider ACM Research (ACMR) After A 241% One Year Surge?

If you are wondering whether ACM Research at around US$53.22 is still a sensible entry point or if too much optimism is already baked in, you are not alone. The stock has seen sharp moves, with returns of 18.6% over the last week, 34.8% over the last month, 18.6% year to date, 240.7% over one year and 391.9% over three years. These shifts can influence how the market views its potential and its risk. Recent coverage has highlighted ACM Research as a key player supplying cleaning equipment to...
NYSE:GAP
NYSE:GAPSpecialty Retail

Assessing Gap (GPS) Valuation After UBS Upgrade And Renewed Growth Optimism

Recent analyst upgrades, led by UBS shifting Gap (GAP) to a more positive rating, have renewed investor focus on the retailer as the market evaluates its beauty offerings, handbag lines, Athleta brand and trends in store traffic. See our latest analysis for Gap. Those upgrades and reports around Gap's comeback sit against a share price of US$28.32, with a 90 day share price return of 43.76% and a 1 year total shareholder return of 20.92%. This suggests momentum has been building rather than...
NasdaqGS:FORM
NasdaqGS:FORMSemiconductor

Is It Too Late To Consider FormFactor (FORM) After Its 172% Three Year Surge?

For investors wondering whether FormFactor is still reasonably priced after its recent run, or if expectations are already reflected in the share price, this article walks through what the current price might be implying. The stock last closed at US$68.64, with returns of 16.0% over the past week, 18.1% over the past month, 16.0% year to date, 55.2% over 1 year and 172.9% over 3 years, while the 5 year return stands at 40.6%. These moves have put FormFactor on more investors' radars, and...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Fastenal (FAST) Valuation Check After Revenue Growth And EBITDA Miss Spurs Market Reaction

Fastenal (FAST) has been in focus after reporting quarterly revenue of US$2.13b, up 11.7% year on year, alongside an EBITDA miss and a 10.3% decline in the share price since the release. See our latest analysis for Fastenal. The recent 10.3% share price decline after the earnings release comes against a longer run of stronger performance, with a 1 year total shareholder return of 19.7% and a 5 year total shareholder return of 87.67%. That context, together with the mixed EBITDA outcome and...
NasdaqGS:WDFC
NasdaqGS:WDFCHousehold Products

How Softer Earnings and Reaffirmed Guidance At WD-40 (WDFC) Have Changed Its Investment Story

WD-40 Company has reported past first-quarter 2026 results showing sales of US$154.42 million, modestly higher year on year, while net income, basic EPS, and diluted EPS all slipped compared with the prior-year period. Despite softer earnings, management reaffirmed its full-year 2026 guidance, highlighted strong growth in WD-40 Specialist and e-commerce channels, and confirmed ongoing share repurchases under its existing buyback authorization. Against this backdrop, we'll assess how...
NYSE:TSN
NYSE:TSNFood

Is Tyson’s Antitrust Settlement With Cargill Reshaping the Investment Case for Tyson Foods (TSN)?

Tyson Foods has agreed in the past to pay US$55.00 million as part of an US$87.50 million settlement with Cargill to resolve an antitrust class action alleging they and other beef processors coordinated to raise consumer beef prices, while denying wrongdoing and awaiting final court approval. The settlement not only addresses a long-running legal overhang but also introduces non-monetary commitments that could influence Tyson’s competitive behavior and regulatory scrutiny across the beef...
NasdaqGS:FCFS
NasdaqGS:FCFSConsumer Finance

A Look At FirstCash Holdings (FCFS) Valuation After A Strong 1 Year Share Price Run

What stands out about FirstCash Holdings right now FirstCash Holdings (FCFS) is back on many investors’ screens after a solid run over the past year, prompting a closer look at how its pawn and retail POS payment operations are positioned today. See our latest analysis for FirstCash Holdings. With the share price at $164.91, FirstCash’s recent 7 day share price return of 5.19% and 90 day share price return of 9.42% sit alongside a 1 year total shareholder return of 56.53%, suggesting momentum...
NasdaqGS:MAT
NasdaqGS:MATLeisure

Is Mattel (MAT) Pricing Reflect Its DCF Upside And Recent Share Price Gains

If you are trying to figure out whether Mattel's current share price lines up with its underlying worth, this is a good moment to step back and look closely at what the market might be pricing in. Mattel's shares recently closed at US$21.48, with returns of 7.2% over the past week, 2.7% over the last month, 7.2% year to date and 15.0% over the past year, which may reflect shifting views on both its potential and its risks. Recent coverage of Mattel has focused on its position in the branded...
NasdaqGS:BILI
NasdaqGS:BILIInteractive Media and Services

Bilibili (NasdaqGS:BILI) Valuation Check As Profitability, AI Ads And Buybacks Reshape Its Turnaround Story

Bilibili (BILI) has captured investor attention after shifting from losses to consistent profitability, with margins improving and advertising revenues accelerating, helped by e-commerce and AI-driven ads, as well as a new share buyback program. See our latest analysis for Bilibili. That profitability shift appears to be feeding into sentiment, with the share price at US$29.17 and recent momentum firming, including a 15.11% 30 day share price return and an 82.66% 1 year total shareholder...
NYSE:TFX
NYSE:TFXMedical Equipment

Teleflex (TFX) Valuation After 2025 Outlook Cut And CEO Change

What triggered the latest Teleflex stock reaction Teleflex (TFX) shares moved after the company cut its 2025 revenue outlook and announced leadership changes, including the departure of long standing CEO Liam Kelly and the appointment of interim CEO Stuart Randle. See our latest analysis for Teleflex. Those guidance cuts and leadership changes came after a weaker patch, with a 30 day share price return of 11.35% and a 1 year total shareholder return decline of 34.67%, showing momentum has...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Is It Too Late To Reassess Liquidia (LQDA) After Its Sharp Share Price Surge?

If you are wondering whether Liquidia's share price still offers value after a strong run, the starting point is understanding how its current market price lines up with different ways of estimating worth. Liquidia's stock closed at US$35.86, with returns of 14.2% over the past week, 9.7% over the past month and 14.2% year to date, while the 1 year return sits at 194.2% and the 3 year return is very large. Recent attention on Liquidia has centered on its position in pharmaceuticals and...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

Assessing Pacira BioSciences (PCRX) Valuation After Record EXPAREL Quarter Buybacks And Activist Pressure

What triggered the latest move in Pacira BioSciences? Pacira BioSciences (PCRX) has drawn attention after reporting record EXPAREL sales with 7% volume growth in what it called its strongest fourth quarter in three years, along with a completed fourth quarter share repurchase and fresh activist pressure on the board. See our latest analysis for Pacira BioSciences. Despite record EXPAREL sales and a completed buyback that retired 13.28% of shares under the May 2025 program, Pacira BioSciences’...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Is Bruker (BRKR) Pricing Looked At Differently After Recent Share Price Rebound?

If you are trying to figure out whether Bruker is attractively priced right now, it helps to compare how the market is treating the stock with what its fundamentals might justify. The share price closed at US$54.46, with returns of 13.2% over the past week and 16.1% over the past month, while the 1-year return sits at a 10.0% decline and the 3-year and 5-year returns are declines of 19.6% and 6.3% respectively. These figures can change how investors think about both potential upside and...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Assessing Royalty Pharma (RPRX) Valuation After Dividend Increase And Raised Full Year Guidance

Royalty Pharma (RPRX) has drawn fresh attention after its board approved a 6.8% increase in the quarterly dividend to US$0.235 per Class A share, along with raised full year guidance following recent results. See our latest analysis for Royalty Pharma. The dividend increase and higher full year guidance come after a period of improving momentum, with the share price at US$40.17, a 90 day share price return of 11.55% and a 1 year total shareholder return of 39.65%, suggesting sentiment has...
NYSE:ELV
NYSE:ELVHealthcare

Is It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Weakness

If you are wondering whether Elevance Health shares offer good value right now, the story starts with how the current price lines up against a few different valuation checks. The stock last closed at US$372.83, with returns of 5.2% over the past week, 9.3% over the past month, 5.2% year to date, a 0.3% decline over the past year, a 19.2% decline over three years, and 22.2% over five years, which gives investors a mixed set of signals about recent momentum and longer term performance. Recent...